Homeostatic Left Heart integration and disintegration links atrio-ventricular covariation's dyshomeostasis in

Paolo Piras1,2, Concetta Torromeo1, Antonietta Evangelista3

  • 1Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza - Università di Roma, Rome, Italy.

Scientific Reports
|July 26, 2017
PubMed

Insights

This study reveals impaired left heart function in hypertrophic cardiomyopathy by analyzing the left ventricle and left atrium together. We found distinct changes in their combined trajectory and how their shapes change together.

Area of Science:

  • Cardiovascular Physiology
  • Biomedical Engineering
  • Cardiac Mechanics

Background:

  • Cardiovascular investigations traditionally analyze the left ventricle and left atrium separately.
  • Echocardiography has advanced understanding of systolic-diastolic differences and chamber-specific impairments.
  • Recent trajectory-based methods offer insights into individual chamber function in conditions like hypertrophic cardiomyopathy.

Purpose of the Study:

  • To investigate the concomitant function and geometrical/mechanical relationship between the left ventricle and left atrium.
  • To analyze the trajectory attributes of the entire left heart as a whole and the shape covariation of its subunits.
  • To contrast these parameters in healthy subjects versus patients with hypertrophic cardiomyopathy.

Main Methods:

  • Acquisition of synchronized left ventricle and left atrium geometries within the same heartbeat.
  • Application of trajectory-based analysis to assess the entire left heart's motion and shape.
  • Evaluation of shape covariation between the left ventricle and left atrium.

Main Results:

  • Impairments in the left heart's overall trajectory, specifically in orientation and size, were observed.
  • Significant differences in the direction of morphological covariation between the left ventricle and left atrium were identified.
  • These findings highlight altered inter-chamber dynamics in hypertrophic cardiomyopathy.

Conclusions:

  • The study provides the first analysis of the concomitant function of the left ventricle and left atrium as a unified system.
  • Altered left heart trajectory and inter-chamber shape covariation offer new insights into hypertrophic cardiomyopathy pathophysiology.
  • This approach enables a more comprehensive evaluation of cardiovascular diseases by considering the integrated function of the left heart chambers.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
726